ARAS

Dead / Cancelled — Cancelled — Section 8 (as of 24 Sept 2021)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
86050419
Registration number
4689448
Mark type
Stylized text
Filed
28 Aug 2013
Published for opposition
19 Aug 2014
Registered
17 Feb 2015
Attorney of record
Steven M. Rabin

Goods and services

  • Class 005 — Pharmaceuticals: Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases

Owner

Prosecution history

  • 24 Sept 2021 — CANCELLED SEC. 8 (6-YR)
  • 17 Feb 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 17 Feb 2015 — REGISTERED-PRINCIPAL REGISTER
  • 15 Jan 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 14 Jan 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 14 Jan 2015 — STATEMENT OF USE PROCESSING COMPLETE
  • 05 Dec 2014 — USE AMENDMENT FILED
  • 13 Jan 2015 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 05 Dec 2014 — TEAS STATEMENT OF USE RECEIVED
  • 14 Oct 2014 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 19 Aug 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 19 Aug 2014 — PUBLISHED FOR OPPOSITION
  • 30 Jul 2014 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 12 Jul 2014 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 03 Jul 2014 — ASSIGNED TO LIE

View this trademark record on Marksy